Global drug giants double down on China amid trend to build self-reliant supply chains

South China Morning PostCenter-RightEN 2 min read 100% complete by Julie ZhangMarch 20, 2026 at 07:30 AM

AI Summary

short article 2 min

AstraZeneca is investing $15 billion in China by 2030, establishing new drug manufacturing facilities in Guangzhou and Shanghai, and an innovation center in Shanghai. This move, announced during UK Prime Minister Keir Starmer's visit, reflects a trend of foreign pharmaceutical companies increasing local production in China. The Guangzhou facility will produce radioconjugate cancer drugs for China and the Asia-Pacific region, while the Shanghai plant will focus on cell therapy. The innovation center will be located in the Zhangjiang Hi-Tech Park. These investments are driven by China's manufacturing capabilities, integrated supply chain, cost advantages, and the companies' long-term commitment to the Chinese market.

Key Entities & Roles

Key Player Opposition Context

Zhang Jialin 30% Zhangjiang Hi-Tech Park 30% Lingang Special Area 30% United Kingdom 40% Nomura 40% Keir Starmer 50% Shanghai ×270% Guangzhou ×270% China ×480% AstraZeneca ×590%

Keywords

china 90% drug manufacturing 90% astrazeneca 80% supply chains 70% pharmaceutical 60% innovation center 60% foreign investment 50% cancer drugs 50% radioconjugate 40% cell therapy 40%

Sentiment Analysis

Positive

Score: 0.30

Source Transparency

Source

South China Morning Post

Political Lean

Center-Right (0.50)

Far LeftCenterFar Right

Classification Confidence

90%

Geographic Perspective

China

This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).

Topic Connections

Explore how the topics in this article connect to other news stories

Network visualization showing 2 related topics

View Full Graph

china drug manufacturing astrazeneca supply chains pharmaceutical innovation center foreign investment cancer drugs radioconjugate cell therapy

Explore Full Topic Graph

Find Similar Articles

AI-Powered

Discover articles with similar content using semantic similarity analysis.